FindTrial
Sign In

Study of oral cancer

Evaluation of tumour budding as a prognostic marker in oral squamous cell carcinoma - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/059759
Enrollment
150
Registered
2023-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C01- Malignant neoplasm of base of tongue Health Condition 2: C049- Malignant neoplasm of floor of mouth, unspecified Health Condition 3: C039- Malignant neoplasm of gum, unspecified Health Condition 4: C009- Malignant neoplasm of lip, unspecified Health Condition 5: C069- Malignant neoplasm of mouth, unspecified Health Condition 6: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx Health Condition 7: C029- Malignant neoplasm of tongue, unspecified

Interventions

Control Intervention1: Nil: Nil

Sponsors

Dr Amit Kumar Chowhan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Surgically resected specimens of oral cavity and diagnosed as Squamous Cell Carcinoma on histopathological examination will be included in the study.

Exclusion criteria

Exclusion criteria: History of chemotherapy or radiation therapy prior to surgery will be excluded.

Design outcomes

Primary

MeasureTime frame
Tumour buddingTimepoint: Three months—

Secondary

MeasureTime frame
understand association of tumour budding with epithelial mesenchymal transition phenomenonTimepoint: Three months—

Countries

India

Contacts

Public ContactDr Amit Kumar Chowhan

All India Institute of Medical Sciences (AIIMS), Raipur

chowhanpath@aiimsraipur.edu.in9490398668

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026